Cargando…
Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening
BACKGROUND: Duchenne muscular dystrophy (DMD) is a devastating muscle wasting disease caused by mutations in dystrophin, a muscle cytoskeletal protein. Utrophin is a homologue of dystrophin that can functionally compensate for its absence when expressed at increased levels in the myofibre, as shown...
Autores principales: | Moorwood, Catherine, Lozynska, Olga, Suri, Neha, Napper, Andrew D., Diamond, Scott L., Khurana, Tejvir S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197614/ https://www.ncbi.nlm.nih.gov/pubmed/22028826 http://dx.doi.org/10.1371/journal.pone.0026169 |
Ejemplares similares
-
Translational Regulation of Utrophin by miRNAs
por: Basu, Utpal, et al.
Publicado: (2011) -
Genome Editing-Mediated Utrophin Upregulation in Duchenne Muscular Dystrophy Stem Cells
por: Sengupta, Kasturi, et al.
Publicado: (2020) -
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies
por: Soblechero‐Martín, Patricia, et al.
Publicado: (2021) -
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019) -
PMO-based let-7c site blocking oligonucleotide (SBO) mediated utrophin upregulation in mdx mice, a therapeutic approach for Duchenne muscular dystrophy (DMD)
por: Sengupta, Kasturi, et al.
Publicado: (2020)